Aflibercept 8 mg recommended for marketing authorization in EU for third retinal indication: Berlin Monday, December 15, 2025, 13:00 Hrs [IST] The Committee for Medicinal Products ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback